Clorox Co.

Clorox Co.

CLX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$12.14B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Clorox Co.Clorox Co.18.35.66%652%1.861.3

Earnings Call Q1 2025

October 30, 2024 - AI Summary

**Strong Q1 Performance**: Clorox reported a solid 31% organic revenue growth in Q1, successfully restoring market share to pre-cyberattack levels while transitioning to a focus on innovation and promotional spending to sustain growth in a challenging consumer environment.
**Market Share Recovery and Outlook**: The company has fully restored overall market share and saw growth across almost all categories. However, future share growth is expected to be lumpy as the company laps the prior year's cyberattack disruptions, with expectations to maintain solid share growth by year-end.
**Challenging Consumer Environment**: Clorox anticipates continued pressure on consumers, leading to increased value-seeking behavior which may affect overall category growth. The company expects U.S. category growth to slow to low single-digit increases, with private label competition remaining normal but not significantly impacting Clorox's share.

Exclusive for Stockcircle Pro members

Sign upSign Up
$93.55

Target Price by Analysts

6.1% downsideClorox Target Price DetailsTarget Price
$187.12

Current Fair Value

87.8% upside

Undervalued by 87.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$12.14 Billion
Enterprise Value$17.51 Billion
Annual dividend$4.98
Dividend yield5.66%
Earnings per Share$4.82
Beta0.58
Outstanding Shares121,775,000

Return

Return on Equity652.22%ROE
Return on Assets7.53%
Return on Invested Capital18.58%

Valuation & Multiples

P/E Ratio18.26P/E Ratio
PEG-35.87PEG
Price to Sales1.81Price to Sales
Price to Book Ratio49.83Price to Book Ratio
Enterprise Value to Revenue2.61
Enterprise Value to EBIT18.77
Enterprise Value to Net Income29
Total Debt to Enterprise0.32
Debt to Equity61.33Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 3, 2026
EPS Estimate
$1.09
Consensus analyst estimate
Revenue Estimate
$1.88 B
Consensus analyst estimate

Next Earnings Call

Expected Date
February 2, 2027
EPS Estimate
$0.98
Consensus analyst estimate
Revenue Estimate
$1.87 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 75.77%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %6.41%▼ 80.13%
Total Invested$631.81M▼ 93.71%
Investors Holding381▼ 723.00%

About Clorox Co.

8,800 employees
CEO: Benno Dorer

The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...

Clorox Insider Information FAQ

Stockcircle tracks 9 top investors with a current 13F position in Clorox. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 6 top investors increased or opened positions and 8 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle lists 4 politician trade disclosures tied to Clorox in the last twelve months, drawn from periodic financial disclosure reports. For example, Donald J Trump bought Clorox in May 2026.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.